Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Domicilium Real Estate Fund III LP

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Eloxx Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock, $0.01 par value per share

(Title of Class of Securities)

(CUSIP Number)

06/05/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Domicilium Capital Partners LLC

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 854,973.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 854,973.00

Aggregate Amount Beneficially Owned by Each Reporting Person

854,973.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

19.99 %

Type of Reporting Person (See Instructions)

IA, OO

Comment for Type of Reporting Person: Excludes pre-funded warrants held by the Reporting Persons in excess of a 19.99% beneficial ownership limitation.

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Domicilium Real Estate Fund III LP

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 238,422.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 238,422.00

Aggregate Amount Beneficially Owned by Each Reporting Person

238,422.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

5.9 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Domicilium Real Estate Fund III GP LLC

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 238,422.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 238,422.00

Aggregate Amount Beneficially Owned by Each Reporting Person

238,422.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

5.9 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

BKJLAGG, LLC

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 602,266.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 602,266.00

Aggregate Amount Beneficially Owned by Each Reporting Person

602,266.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

14.1 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person: Excludes pre-funded warrants held by the Reporting Persons in excess of a 19.99% beneficial ownership limitation.

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

MSEK Charleston LLC

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 240,688.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 240,688.00

Aggregate Amount Beneficially Owned by Each Reporting Person

240,688.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

5.6 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person: Excludes pre-funded warrants held by the Reporting Persons in excess of a 19.99% beneficial ownership limitation.

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Bold Stroke Investments, LLC

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 240,688.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 240,688.00

Aggregate Amount Beneficially Owned by Each Reporting Person

240,688.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

5.6 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person: Excludes pre-funded warrants held by the Reporting Persons in excess of a 19.99% beneficial ownership limitation.

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Daniel Simon

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 854,973.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 854,973.00

Aggregate Amount Beneficially Owned by Each Reporting Person

854,973.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

19.99 %

Type of Reporting Person (See Instructions)

HC, IN

Comment for Type of Reporting Person: Excludes pre-funded warrants held by the Reporting Persons in excess of a 19.99% beneficial ownership limitation.

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

Eloxx Pharmaceuticals, Inc.

(b)

Address of issuer's principal executive offices:

P.O. Box 274, 10 Court Street, Arlington, MA 02476

Item 2.

(a)

Name of person filing:

Domicilium Capital Partners LLC Domicilium Real Estate Fund III LP Domicilium Real Estate Fund III GP LLC BKJLAGG, LLC MSEK Charleston LLC Bold Stroke Investments, LLC Daniel Simon

(b)

Address or principal business office or, if none, residence:

Domicilium Capital Partners LLC 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092 Domicilium Real Estate Fund III LP 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092 Domicilium Real Estate Fund III GP LLC 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092 BKJLAGG, LLC 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092 MSEK Charleston LLC 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092 Bold Stroke Investments, LLC 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092 Daniel Simon 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092

(c)

Citizenship:

Domicilium Capital Partners LLC - Delaware Domicilium Real Estate Fund III LP - Delaware Domicilium Real Estate Fund III GP LLC - Delaware BKJLAGG, LLC - Delaware MSEK Charleston LLC - Delaware Bold Stroke Investments, LLC - Delaware Daniel Simon - United States

(d)

Title of class of securities:

Common Stock, $0.01 par value per share

(e)

CUSIP No.:

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

Domicilium Capital Partners LLC - 854,973 Domicilium Real Estate Fund III LP - 238,422 Domicilium Real Estate Fund III GP LLC - 238,422 BKJLAGG, LL - 602,266 MSEK Charleston LLC - 240,688 Bold Stroke Investments, LLC - 240,688 Daniel Simon - 854,973

(b)

Percent of class:

Domicilium Capital Partners LLC - 19.99% Domicilium Real Estate Fund III LP - 5.9% Domicilium Real Estate Fund III GP LLC - 5.9% BKJLAGG, LL - 14.1% MSEK Charleston LLC - 5.6% Bold Stroke Investments, LLC - 5.6% Daniel Simon - 19.99% %

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

Domicilium Capital Partners LLC - 0 Domicilium Real Estate Fund III LP - 0 Domicilium Real Estate Fund III GP LLC - 0 BKJLAGG, LLC - 0 MSEK Charleston LLC - 0 Bold Stroke Investments, LLC - 0 Daniel Simon - 0

(ii) Shared power to vote or to direct the vote:

(iii) Sole power to dispose or to direct the disposition of:

(iv) Shared power to dispose or to direct the disposition of:

Item 5.

Ownership of 5 Percent or Less of a Class.

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.

All of the securities reported in this Schedule 13G are directly owned by advisory clients of Domicilium Capital Partners LLC. None of those advisory clients, except for the advisory clients reported herein, may be deemed to beneficially own more than 5% of the Common Stock, $0.01 par value per share.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Domicilium Capital Partners LLC

Signature:	/s/ Daniel Simon
Name/Title:	Daniel Simon, Managing Member of its general partner
Date:	06/17/2026

Domicilium Real Estate Fund III LP

Signature:	/s/ Daniel Simon
Name/Title:	Daniel Simon, Managing Member
Date:	06/17/2026

Domicilium Real Estate Fund III GP LLC

Signature:	/s/ Daniel Simon
Name/Title:	Daniel Simon, Managing Member
Date:	06/17/2026

BKJLAGG, LLC

Signature:	/s/ Daniel Simon
Name/Title:	Daniel Simon, Managing Member
Date:	06/17/2026

MSEK Charleston LLC

Signature:	/s/ Daniel Simon
Name/Title:	Daniel Simon, Managing Member
Date:	06/17/2026

Bold Stroke Investments, LLC

Signature:	/s/ Daniel Simon
Name/Title:	Daniel Simon, Managing Member
Date:	06/17/2026

Daniel Simon

Signature:	/s/ Daniel Simon
Name/Title:	Daniel Simon
Date:	06/17/2026

Exhibit Information

Exhibit A - Joint Filing Agreement

StreetInsider

Log in to your account:

Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Domicilium Real Estate Fund III LP

Categories